Ferobest Iron Sucrose Injection - USP
- Consumables & Disposables
- Critical Care & ICU Equipment
- Dental Equipment & Instruments
- Derma Products
- Diagnostics & Lab Equipment
- Home Care & Rehabilitation
- Hospital Furniture
- Operation Theatre (OT) Equipment
- Orthopedic & Prosthetics
- Others
- Pharma & Wellness
- Surgical Instruments
- Veterinary & Niche Medical Equipment
Your shopping cart is empty!
Product Description
Effectively manage iron deficiency anemia in chronic kidney disease (CKD) patients with Iron Sucrose Injection. This vital intravenous iron supplement is specifically indicated for dialysis patients (both hemodialysis and peritoneal) and non-dialysis CKD patients who require rapid and efficient iron repletion.
Iron Sucrose is a preferred choice in renal care due to its favorable safety profile and reduced risk of side effects compared to older iron formulations. It provides a bioavailable source of iron that is quickly absorbed and utilized for the production of healthy red blood cells, helping to alleviate anemia symptoms and improve patient outcomes. Ensure your patients receive the essential iron support they need with this reliable and well-tolerated injection.
Features
-
Targeted Anemia Treatment: Specifically formulated to treat iron deficiency anemia in patients with Chronic Kidney Disease (CKD), including those on dialysis.
-
Preferred Safety Profile: Associated with fewer side effects compared to other IV iron complexes like iron dextran, making it a trusted choice for sensitive CKD patients.
-
Rapid & Efficient Action: Administered intravenously for quick absorption and direct utilization by the body to support red blood cell production.
-
Broad CKD Patient Suitability: Effective for both dialysis-dependent (hemodialysis/peritoneal) and non-dialysis CKD patients suffering from iron deficiency.
-
Supports Hematopoietic Function: Replenishes iron stores directly, which is essential for the synthesis of hemoglobin and overall improvement of anemia.
Specifications
|
Category
|
Specification
|
Details
|
|---|---|---|
|
General
|
Product Name
|
Iron Sucrose Injection
|
|
|
Drug Class
|
Intravenous Iron Supplement
|
|
Indications & Use
|
Primary Use
|
Treatment of Iron Deficiency Anemia in CKD patients
|
|
|
Patient Population
|
Dialysis (HD/PD) and Non-Dialysis CKD patients
|
|
Administration
|
Route
|
Intravenous (IV)
|
|
Key Benefit
|
Clinical Advantage
|
Fewer side effects, preferred in CKD over iron dextran
|
